iShares Core SandP Mid-Cap ETF (IJH)
Live price chart, market sentiment, and community perspectives for iShares Core SandP Mid-Cap ETF (AMEX: IJH).
Live price chart, market sentiment, and community perspectives for iShares Core SandP Mid-Cap ETF (AMEX: IJH).
On our macro desk, we are noticing a distinct sector rotation away from mega-cap tech into mid-cap blends like IJH. The fund's first-half price return of 15% outclassed the SandP 500's 8.5% advance. With net assets topping $123 billion and a rock-bottom expense ratio of 0.05%, institutional allocators are finding it an extremely cost-effective vehicle to capture broad US economic exposure without paying heavy management fees.
Looking at the quantitative risk metrics for IJH, we see a 3-year standard deviation hovering around 15.89% to 17.61% and a beta right near 1.01. While it boasts solid diversification with over 407 holdings—where the top ten holdings account for a minuscule 7.76% to 7.79% of total assets—risk managers need to account for its historical drawdown capacity, specifically its worst 3-month performance drop of -15.69%.
From a sentiment standpoint, market commentary on Seeking Alpha has turned increasingly constructive on mid-caps for 2026. Investors are looking past pure mega-cap growth and rotating capital downward into asset classes that benefit from favorable fundamental backdrops. However, short-term technical screens like Market Edge's Second Opinion show a mild deteriorating score of -2, advising caution against aggressively chasing new long positions right here.
When evaluating candidate positioning for mid-cap exposure, I always check the fundamental valuation multiples. IJH is trading at a P/E ratio around 22.47 to 23.36 and a P/B ratio of 2.86. Given that the SandP MidCap 400 index is heavily weighted toward Industrials (roughly 22% to 23%), Financials (approx 15%), and Information Technology (around 14% to 16%), analysts must weigh industrial cycle sensitivities against tech growth.
As a quant reviewing the trade execution data, average daily volume sits robustly between 4.39M and 6.36M shares against a massive AUM of roughly $123.7B to $125.5B. Bid-ask spreads remain exceptionally tight, and the fund's tiny premium/discount of 0.05% demonstrates excellent intraday tracking efficiency relative to the underlying SandP MidCap 400 benchmark index.
Explore plasma cleansing, somatic organ swaps, and BCI.